In summary, DTL and DTX3L have multiple pro cancer functions in the development of CM, not only participating in metabolic recombination and signal transduction regulation, but also having important clinical translational value, suggesting that they can serve as potential diagnostic markers and therapeutic targets. This evidence concerns the gene DTX3L and cancer.